Market›Health Care›Life Sciences Tools & Services›Life Sciences Tools & Services
OXFORD NANOPORE TECH

ONTTF

$1.67Oct 15, 2021 – Apr 24, 2026
Health CareLife Sciences Tools & Services$1.48B
MVM
+$33.9M
TD Variance
7.143

Every news event mapped to its market reaction — 43 events, 55 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-09-03+18.4%newsSeeking AlphaOxford Nanopore reports 1H results
2024-09-03+18.4%earningsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Q2 2024 Earnings Call Transcript
2024-09-03+18.4%earningsSeeking AlphaOxford Nanopore Technologies plc 2024 Q2 - Results - Earnings Call Presentation
2022-03-22+15.4%earningsSeeking AlphaOxford Nanopore Technologies Limited (ONTTF) CEO Gordon Sanghera on Q4 2021 Results - Earnings Call Transcript
2023-03-21+14.0%earningsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Q4 2022 Earnings Call Transcript
2023-03-21+14.0%newsSeeking AlphaOxford Nanopore reports FY results
2023-10-19+13.2%newsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) 2023 Capital Markets Day (Transcript)
2026-03-02-12.1%earningsMarketBeatOxford Nanopore Technologies H2 Earnings Call Highlights
2026-03-02-12.1%earningsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call Transcript
2026-03-02-12.1%newsSeeking AlphaOxford Nanopore reports FY results
2026-03-02-12.1%earningsSeeking AlphaOxford Nanopore Technologies plc 2025 Q4 - Results - Earnings Call Presentation (OTCMKTS:ONTTF) 2026-03-02 - Seeking Alpha
2026-02-27-11.8%earningsGuruFocus.comOxford Nanopore Technologies PLC (LSE:ONT) Q4 2025 Earnings Report Preview: What To Look For
2025-09-02-9.9%earningsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call Transcript
2025-09-02-9.9%earningsSeeking AlphaOxford Nanopore Technologies plc 2025 Q2 - Results - Earnings Call Presentation
2025-03-04-9.8%earningsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Q4 2024 Earnings Call Transcript
2026-03-11+9.6%newsMarketBeatOxford Nanopore Technologies Conference: Clinical Sales Surge as Growth Targets Reset, Break-Even Delayed
2026-03-11+9.6%newsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
2024-03-06+9.1%earningsSeeking AlphaOxford Nanopore GAAP EPS of -19p, revenue of 169.7M
2024-03-07+8.7%earningsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Full Year 2023 Earnings Call Transcript
2026-04-19-8.2%newsSimply Wall St.Agilent Cancer Research Push Spurs Collaboration Focus And Investor Reassessment
2026-04-18-8.2%earningsSimply Wall St.How Danaher’s Expanded Infectious Disease Partnership Could Shape DHR’s Recurring Revenue Story
2026-03-10-8.0%executivebusinesscloud.co.ukOxford Nanopore shares rise under new CEO after company update - businesscloud.co.uk
2023-09-06-7.9%earningsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Q2 2023 Earnings Call Transcript
2025-12-02-7.7%newsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
2023-02-06-5.4%newsSeeking AlphaIllumina, Pacific Biosciences, And Oxford Nanopore Market Position Comparison - Seeking Alpha
2022-09-13+5.2%earningsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Q2 2022 Earnings Call Transcript
2022-09-13+5.2%newsSeeking AlphaOxford Nanopore reports 1H results
2024-08-04+4.7%newsYahoo FinanceOxford Nanopore Technologies plc (LON:ONT) is largely controlled by institutional shareholders who own 50% of the company - Yahoo Finance
2026-04-15+4.7%expansionPR NewswireCepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration
2025-03-05-4.2%newsSeeking AlphaIllumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race - Seeking Alpha
2026-03-03+4.0%earningsSeeking AlphaOxford Nanopore Technologies plc 2025 Q4 - Results - Earnings Call Presentation
2025-04-24-3.9%newsStock TitanONTTF Stock Price, News & Analysis - Stock Titan
2021-12-28+3.6%newsSeeking AlphaOxford Nanopore: Oxford University Spin-Out Disrupting Biological Analyses
2022-09-27-3.2%earningsSeeking AlphaOxford Nanopore Technologies plc 2022 Q2 - Results - Earnings Call Presentation
2026-04-12-3.0%newsThe Motley FoolBest Genetic Sequencing Stocks for 2026 and How to Invest in Them - The Motley Fool
2026-03-31-3.0%newsSimply Wall St.This Oxford Nanopore Technologies Insider Increased Their Holding By 17% Last Year
2024-01-17+2.9%newsSeeking AlphaOxford Nanopore Stock: Ultra-Long Reads In A Short-Term Slump (OTCMKTS:ONTTF) - Seeking Alpha
2023-02-08-1.7%newsSeeking AlphaOxford Nanopore: Illumina's Formidable Challenger
2026-04-13+1.4%newsGlobeNewswireKeys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead
2026-01-13+1.2%newsSeeking AlphaOxford Nanopore Technologies plc (ONTTF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2023-03-24+0.8%M&ASeeking AlphaOxford Nanopore: Attractive Long-Term Growth, Possible Buyout Scenario
2022-04-12-0.8%newsThe Motley Fool3 Things About Pacific Biosciences of California That Smart Investors Know - The Motley Fool
2024-01-18+0.6%newsSeeking AlphaOxford Nanopore: Ultra-Long Reads In A Short-Term Slump
tickerdossier.comtickerdossier.substack.com